Ajasin et al., 2019 - Google Patents
CCL2 mobilizes ALIX to facilitate Gag-p6 mediated HIV-1 virion releaseAjasin et al., 2019
View HTML- Document ID
- 270352592946291117
- Author
- Ajasin D
- Rao V
- Wu X
- Ramasamy S
- Pujato M
- Ruiz A
- Fiser A
- Bresnick A
- Kalpana G
- Prasad V
- Publication year
- Publication venue
- Elife
External Links
Snippet
Cellular ESCRT machinery plays pivotal role in HIV-1 budding and release. Extracellular stimuli that modulate HIV-1 egress are currently unknown. We found that CCL2 induced by HIV-1 clade B (HIV-1B) infection of macrophages enhanced virus production, while CCL2 …
- 241000713772 Human immunodeficiency virus 1 0 title abstract description 101
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ajasin et al. | CCL2 mobilizes ALIX to facilitate Gag-p6 mediated HIV-1 virion release | |
| Lahaye et al. | NONO detects the nuclear HIV capsid to promote cGAS-mediated innate immune activation | |
| Usami et al. | SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef | |
| Barr et al. | The interferon response inhibits HIV particle production by induction of TRIM22 | |
| Rosa et al. | HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation | |
| Yedavalli et al. | Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function | |
| Sharova et al. | Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction | |
| Valera et al. | The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation | |
| Carthagena et al. | Implication of TRIMalpha and TRIMCyp in interferon-induced anti-retroviral restriction activities | |
| Yin et al. | Equine tetherin blocks retrovirus release and its activity is antagonized by equine infectious anemia virus envelope protein | |
| Martin et al. | APOBEC3G complexes decrease human immunodeficiency virus type 1 production | |
| Dwivedi et al. | HIV-1 capsid and viral DNA integration | |
| Jackson et al. | Sequence and functional variation in the HIV-1 Rev regulatory axis | |
| Xiong et al. | C19ORF66 is an interferon-stimulated gene (ISG) which Inhibits human immunodeficiency virus-1 | |
| Kim et al. | Identification of a novel type of small molecule inhibitor against HIV-1 | |
| Rezaei et al. | Ectopic USP15 expression inhibits HIV-1 transcription involving changes in YY1 deubiquitination and stability | |
| Gonzalez et al. | Understanding the Mutual Antagonism Between HIV and Autophagy | |
| Tamburello | Functional analysis of interaction between primary HIV-1 nef alleles and host proteins | |
| Bunten | Host Cell Peptidylprolyl cis-trans Isomerases as Immune Modulators of HIV-1 Infection | |
| Laguette et al. | Manipulation of the host cell by viral auxiliary proteins | |
| Yi | A zinc-finger-containing protein ZCCHC3 is an anti-retroviral host factor | |
| Ajasin | CCL2 Mobilizes ALIX from Actin Cytoskeleton to Enhance Gag Trafficking and HIV Virion Release-Effect of Gag polymorphism on HIV-1 Viral Fitness | |
| Bhargava | Investigating the relationship between structural elements of the inner nuclear membrane and HIV infection | |
| Ruiz de Andrés | Friends or foes in virus-host interactions: Cell regulation of HIV-1 replication | |
| Danappa Jayappa | Molecular analysis of the contributions of human immunodeficiency virus type-1 integrase in post entry steps of early stage virus replication |